Identification of factors associated with depression chronicity: An analysis of the Canadian Study on Aging (CLSA).

J Affect Disord

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; Department of Population-Based Medicine, Institute of Health Sciences, University Hospital Tuebingen, Tuebingen, Germany. Electronic address:

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Identification of risk factors for depressive chronicity may reduce disease burden by informing prevention and treatment strategies. We aimed to estimate the prevalence of depression chronicity and explore factors linked to chronic depression in a longitudinal cohort.

Methods: Participants from the Canadian Longitudinal Study on Aging Comprehensive cohort who were depressed at baseline, based on a score of 10 or more on the Center for Epidemiologic Studies Depression-10 item scale (CESD-10), were included (n = 3473). Participants were considered to have chronic depression if they maintained a CESD-10 score of 10 or greater at the follow-up. Latent profile analyses (LPA) were used to determine baseline depression subtypes, baseline allostatic load biomarker (AL) profiles, and adverse childhood experience (ACE) profiles. Logistic regression was used to explore factors associated with chronic depression RESULTS: Depression was chronic for 46.6 % of the sample. Significant baseline predictors included depression subtype, with atypical and melancholic subtypes having 1.35 (95 %CI: 1.05-1.73) and 1.87 (95 %CI: 1.53-2.3) times greater odds, respectively, compared with the positive affect subtype. Greater odds of chronic depression were associated with moderate (OR 1.44, 95 %CI: 1.21-1.72) and physical ACE profiles (OR 1.47, 95 %CI: 1.16, 1.84), and with high-cardiovascular AL profile (OR 1.07, 95 %CI: 1.07-1.69), compared with low ACE and average AL profiles. Other significant baseline risk factors included lower annual household income, increased chronic conditions, lower perceived social status, and smoking.

Conclusions: Depression subtypes and stressor profiles were differentially associated with depression chronicity. The research may shed light on intervention and prevention in clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2025.120079DOI Listing

Publication Analysis

Top Keywords

chronic depression
16
depression chronicity
12
depression
11
factors associated
8
associated depression
8
study aging
8
risk factors
8
explore factors
8
depression subtypes
8
ace profiles
8

Similar Publications

[Impact of transcranial magnetic stimulation on depressive symptoms relief in patients with chronic neuropathic pain and comorbid depression: A narrative literature review].

Encephale

September 2025

Centre de référence régional des pathologies anxieuses et de la dépression, pôle de psychiatrie générale et universitaire, centre hospitalier Charles-Perrens, 33076 Bordeaux, France; Inserm U1215, Neurocentre Magendie, 33000 Bordeaux, France. Electronic address:

Neuropathic pain results from an injury or a dysfunction of the somatosensory system. Management of this disease is complex due to a restricted therapeutic arsenal and limited efficacy of currently available treatments. Because of its chronic and disabling nature, neuropathic pain is strongly associated with depressive disorders.

View Article and Find Full Text PDF

Modeling neurodegeneration and neuroinflammation in Parkinson's Disease: Animal-based strategies.

Methods Cell Biol

September 2025

Histology and Cell Biology Department, School of Medicine, Complutense University of Madrid, Madrid, Spain. Electronic address:

Parkinson disease (PD) is the second most prevalent neurodegenerative disorder globally, trailing only Alzheimer´s disease. It currently affects nearly 3 % of individuals aged 65 and above. The disease is characterized by the progressive loss of dopaminergic neurons accompanied by a chronic neuroinflammatory process, which is responsible for both motor symptoms (tremor, rigidity, bradykinesia) and non-motor symptoms (depression, dysphagia, anxiety, constipation, and anosmia).

View Article and Find Full Text PDF

The effect of muscle quality index on the risk of adverse health outcomes: a prospective cohort study of 355,209 adults.

Am J Clin Nutr

September 2025

Department of Geriatrics, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou 3100003, China. Electronic address:

Background: Muscle quality index (MQI), a new metric for assessing sarcopenia, reflects the functional capacity of muscle. However, the associations between MQI and adverse health outcomes and the corresponding mechanisms are not well understood.

Objective: We aimed to prospectively evaluate the associations of MQI with risk of nine adverse health outcomes (ie, osteoarthritis, cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), respiratory disease, chronic kidney disease (CKD), liver disease, dementia, depression, and all-cause mortality), as well as the mediating role of metabolomics in these associations.

View Article and Find Full Text PDF

Blood transcriptomic analysis reveals a distinct molecular subtype of treatment resistant depression compared to non-treatment resistant depression.

Brain Behav Immun

September 2025

Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Biomedical Research Networking Center for Rare Diseases (CIBERER), Barcelona 08003, Spain.

Treatment-resistant depression (TRD) is a severe condition characterized by chronic and recurrent depressive symptoms, leading to significant morbidity and a considerable socio-economic impact. Genetic and biological studies suggest that TRD is associated with distinct biological characteristics. In this study, we analysed whole-transcriptome differences in 293 patients with major depressive disorder (MDD) to compare TRD (N = 150) vs non-TRD (N = 143) cases.

View Article and Find Full Text PDF

Background: Depressive symptoms significantly increase physical morbidity, mortality, and healthcare demands, while chronic diseases can exacerbate depressive symptoms. This study aimed to: 1) determine the prevalence of depressive symptoms among individuals with and without chronic diseases; 2) compare the number of chronic diseases across age groups in those with and without depressive symptoms; and 3) analyze associations between depressive symptoms and chronic diseases, adjusting for sociodemographic, socioeconomic, lifestyle, and health-related variables.

Methods: In this cross-sectional study, data from 275,009 participants (126,642 men, 148,367 women) in the third wave of the European Health Interview Survey (2018-2020) across 30 European countries were analyzed.

View Article and Find Full Text PDF